The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Macular telangiectasia type 2
Open accessAbstract
Macular telangiectasia type 2 is a bilateral disease of unknown cause with characteristic alterations of the macular capillary network and neurosensory atrophy. Its prevalence may be underestimated and has recently been shown to be as high as 0.1% in persons 40 years and older. Biomicroscopy may show reduced retinal transparency, crystalline deposits, mildly ectatic capillaries, blunted venules, retinal pigment plaques, foveal atrophy, and neovascular complexes. Fluorescein angiography shows telangiectatic capillaries predominantly temporal to the foveola in the early phase and a diffuse hyperfluorescence in the late phase. High-resolution optical coherence tomography (OCT) may reveal disruption of the photoreceptor inner segment-outer segment border, hyporeflective cavities at the level of the inner or outer retina, and atrophy of the retina in later stages. Macular telangiectasia type 2 shows a unique depletion of the macular pigment in the central retina and recent therapeutic trials showed that such depleted areas cannot re-accumulate lutein and zeaxanthin after oral supplementation. There have been various therapeutic approaches with limited or no efficacy. Recent clinical trials with compounds that block vascular endothelial growth factor (VEGF) have established the role of VEGF in the pathophysiology of the disease, but have not shown significant efficacy, at least for the non-neovascular disease stages. Recent progress in structure-function correlation may help to develop surrogate outcome measures for future clinical trials. In this review article, we summarize the current knowledge on macular telangiectasia type 2, including the epidemiology, the genetics, the clinical findings, the staging and the differential diagnosis of the disease. Findings using retinal imaging are discussed, including fluorescein angiography, OCT, adaptive optics imaging, confocal scanning laser ophthalmoscopy, and fundus autofluorescence, as are the findings using visual function testing including visual acuity and fundus-controlled microperimetry. We provide an overview of the therapeutic approaches for both non-neovascular and neovascular disease stages and provide a perspective of future directions including animal models and potential therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Adaptive optics scanning laser ophthalmoscopy
Roorda, A., Romero-Borja, F., Donnelly III, W. J., Queener, H., Hebert, T. J., & Campbell, M. C. W. (2002) · Optics Express · doi:10.1364/oe.10.000405 · Cited by 967
Delori, F. C., Dorey, C. K., Staurenghi, G., Arend, O., Goger, D. G., & Weiter, J. J. (1995) · PubMed · Cited by 948
Worthen, D. M. (1972) · Archives of Ophthalmology · doi:10.1001/archopht.1972.01000030236034 · Cited by 798
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
Nishijima, K., Ng, Y.-S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S. J., Robinson, G. S., Adamis, A. P., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061237 · Cited by 707
Histology of the Human Eye: An Atlas and Textbook
(1972) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1972.tb88227.x · Cited by 634
Saint-Geniez, M., Maharaj, A. S. R., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J., & D'Amore, P. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003554 · Cited by 616
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 589
Stereoscopic atlas of macular diseases
Gass, J. D. M. (1977) · Cited by 576
The macular pigment. II. Spatial distribution in primate retinas.
Snodderly, D. M., Auran, J. D., & Delori, F. C. (1984) · PubMed · Cited by 534
Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.
Gass, J. D. M., & Blodi, B. A. (1993) · PubMed · Cited by 507
Protection of mouse photoreceptors by survival factors in retinal degenerations.
LaVail, M. M., Yasumura, D., Matthes, M. T., Lau-Villacorta, C., Unoki, K., Sung, C. –., & Steinberg, R. H. (1998) · PubMed · Cited by 494
Idiopathic Macular Telangiectasia
Yannuzzi, L. A. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.450 · Cited by 474
Idiopathic Juxtafoveolar Retinal Telangiectasis
Gass, J. D. M., & Blodi, B. A. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31447-8 · Cited by 455
Snodderly, D. M., Brown, P. K., Delori, F. C., & Auran, J. D. (1984) · PubMed · Cited by 427
Müller cells are living optical fibers in the vertebrate retina
Franze, K., Grosche, J., Skatchkov, S. N., Schinkinger, S., Foja, C., Schild, D., Uckermann, O., Travis, K., Reichenbach, A., & Guck, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611180104 · Cited by 426
Okamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., La Rochelle, W., Zack, D. J., & Campochiaro, P. A. (1998) · Retina · doi:10.1097/00006982-199805000-00034 · Cited by 365
Tao, W., Wen, R., Goddard, M. B., Sherman, S., O'Rourke, P., Stabila, P. F., Bell, W. J., Dean, B. J., Kauper, K., Budz, V. A., et al. (2002) · PubMed · Cited by 330
Shen, W., Fruttiger, M., Zhu, L., Chung, S. H., Barnett, N. L., Kirk, J. K., Lee, S., Coorey, N. J., Killingsworth, M., Sherman, L. S., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2841-12.2012 · Cited by 267
Self-citationPerifoveal Müller Cell Depletion in a Case of Macular Telangiectasia Type 2
Powner, M. B., Gillies, M. C., Tretiach, M., Scott, A., Guymer, R. H., Hageman, G. S., & Fruttiger, M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.04.001 · Cited by 262
Self-citationBhosale, P., Larson, A. J., Frederick, J. M., Southwick, K., Thulin, C. D., & Bernstein, P. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405334200 · Cited by 261
Retinal assessment using optical coherence tomography
Costa, R. A., Skaf, M., Melo, L. A. S., Calucci, D., Cardillo, J. A., Castro, J. C., Huang, D., & Wojtkowski, M. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.03.001 · Cited by 232
Cayouette, M., Behn, D., Sendtner, M., Lachapelle, P., & Gravel, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09282.1998 · Cited by 228
Liang, F.-Q., Aleman, T. S., Dejneka, N. S., Dudus, L., Fisher, K. J., Maguire, A. M., Jacobson, S. G., & Bennett, J. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0473 · Cited by 222
Cayouette, M., & Gravel, C. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.4-423 · Cited by 219
Bok, D., Yasumura, D., Matthes, M. T., Ruiz, A., Duncan, J. L., Chappelow, A. V., Zolutukhin, S., Hauswirth, W., & LaVail, M. M. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1176 · Cited by 213
Okamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., LaRochelle, W. J., Zack, D. J., & Campochiaro, P. A. (1997) · Europe PMC (PubMed Central) · Cited by 212
Weber, B. H. F., Schrewe, H., Molday, L. L., Gehrig, A., White, K. L., Seeliger, M. W., Jaissle, G. B., Friedburg, C., Tamm, E., & Molday, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092528599 · Cited by 211
Macular Pigment: A Review of Current Knowledge
Whitehead, A. J. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.7.1038 · Cited by 210
Identification of StARD3 as a Lutein-Binding Protein in the Macula of the Primate Retina
Li, B., Vachali, P., Frederick, J. M., & Bernstein, P. S. (2011) · Biochemistry · doi:10.1021/bi101906y · Cited by 198
FITZSIMONS, R. B., GURWIN, E. B., & BIRD, A. C. (1987) · Brain · doi:10.1093/brain/110.3.631 · Cited by 178
Self-citationTobe, T., Okamoto, N., Vinores, M. A., Derevjanik, N. L., Vinores, S. A., Zack, D. J., & Campochiaro, P. A. (1998) · PubMed · Cited by 171
Macular pigment in the human retina: histological evaluation of localization and distribution
Trieschmann, M., van Kuijk, F. J. G. M., Alexander, R., Hermans, P., Luthert, P. J., Bird, A. C., & Pauleikhoff, D. (2007) · Eye · doi:10.1038/sj.eye.6702780 · Cited by 156
Self-citationMOUSE MODEL OF SUBRETINAL NEOVASCULARIZATION WITH CHOROIDAL ANASTOMOSIS
Heckenlively, J. R., Hawes, N. L., Friedlander, M., Nusinowitz, S., Hurd, R. E., Davisson, M. T., & Chang, B. (2003) · Retina · doi:10.1097/00006982-200308000-00012 · Cited by 151
The Prevalence of Macular Telangiectasia Type 2 in the Beaver Dam Eye Study
Klein, R., Blodi, B. A., Meuer, S. M., Myers, C. E., Chew, E. Y., & Klein, R. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.02.013 · Cited by 139
Self-citationThe filling-in process in patients with retinal scotomata
Gerrits, H. J. M., & Timmerman, G. J. M. E. N. (1969) · Vision Research · doi:10.1016/0042-6989(69)90092-3 · Cited by 135
VEGF modulation of retinal pigment epithelium resistance
Ablonczy, Z., & Crosson, C. E. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.08.010 · Cited by 131
Dorrell, M. I., Aguilar, E., Jacobson, R., Yanes, O., Gariano, R., Heckenlively, J., Banin, E., Ramirez, G. A., Gasmi, M., Bird, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35977 · Cited by 127
Self-citationChong, V. N., Alexander, R., Waters, L., Barnett, K. C., Bird, A. C., & Luthert, P. J. (1999) · PubMed · Cited by 120
Self-citationMacular pigments: their characteristics and putative role
Davies, N., & Morland, A. B. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.05.004 · Cited by 114
Microperimetric Assessment of Patients with Type 2 Idiopathic Macular Telangiectasia
Issa, P. C., Helb, H. –., Rohrschneider, K., Holz, F. G., & Scholl, H. P. N. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1272 · Cited by 111
Self-citationIssa, P. C., van der Veen, R. L. P., Stijfs, A., Holz, F. G., Scholl, H. P. N., & Berendschot, T. T. J. M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.02.006 · Cited by 109
Self-citationPurification and Partial Characterization of a Lutein-Binding Protein from Human Retina
Bhosale, P., Li, B., Sharifzadeh, M., Gellermann, W., Frederick, J. M., Tsuchida, K., & Bernstein, P. S. (2009) · Biochemistry · doi:10.1021/bi9004478 · Cited by 108
Reading Performance Is Reduced by Parafoveal Scotomas in Patients with Macular Telangiectasia Type 2
Finger, R. P., Issa, P. C., Fimmers, R., Holz, F. G., Rubin, G. S., & Scholl, H. P. N. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2032 · Cited by 107
Self-citationStructure-Function Correlation of the Human Central Retina
Issa, P. C., Troeger, E., Finger, R. P., Holz, F. G., Wilke, R. G. H., & Scholl, H. P. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012864 · Cited by 92
Self-citationIssa, P. C., Holz, F. G., & Scholl, H. P. N. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.079 · Cited by 91
Self-citationABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull's-eye maculopathy
Michaelides, M., Chen, L., Brantley, M. A., Andorf, J. L., Isaak, E. M., Jenkins, S. A., Holder, G. E., Bird, A. C., Stone, E. M., & Webster, A. R. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.118356 · Cited by 87
Self-citationTHE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2
Aung, K. Z., Wickremasinghe, S., Makeyeva, G. A., Robman, L. D., & Guymer, R. H. (2010) · Retina · doi:10.1097/iae.0b013e3181bd2c71 · Cited by 78
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia
Issa, P. C., Finger, R. P., Holz, F. G., & Scholl, H. P. N. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.129627 · Cited by 76
Self-citationGerth‐Kahlert, C., Zawadzki, R. J., Werner, J. S., & Héon, E. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.6.807 · Cited by 76
Bevacizumab in the treatment of idiopathic macular telangiectasia
Gamulescu, M., Walter, A., Sachs, H. G., & Helbig, H. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0795-6 · Cited by 75
BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II
Kovach, J. L., & Rosenfeld, P. J. (2009) · Retina · doi:10.1097/iae.0b013e31818ba9de · Cited by 75
Familial Asymptomatic Macular Telangiectasia Type 2
Gillies, M. C., Zhu, M., Chew, E. Y., Barthelmes, D., Hughes, E. H., Ali, H., Holz, F. G., Scholl, H. P. N., & Issa, P. C. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.010 · Cited by 74
Self-citationMacular spectral-domain optical coherence tomography in patients with X linked retinoschisis
Gregori, N. Z., Berrocal, A. M., Gregori, G., Murray, T. G., Knighton, R. W., Flynn, H. W., Dubovy, S. R., Puliafito, C. A., & Rosenfeld, P. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.136127 · Cited by 72
Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Pető, T., Figueroa, M. J., & Harrington, M. W. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1749 · Cited by 71
Self-citationMonthly Ranibizumab for Nonproliferative Macular Telangiectasia Type 2: A 12-Month Prospective Study
Issa, P. C., Finger, R. P., Kruse, K., Baumüller, S., Scholl, H. P. N., & Holz, F. G. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.11.019 · Cited by 71
Self-citationSmithen, L., & Spaide, R. F. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.05.073 · Cited by 70
Willemsen, M. A. A. P., Cruysberg, J. R. M., Rotteveel, J. J., Aandekerk, A. L., van Domburg, P. H. M. F., & Deutman, A. F. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00576-6 · Cited by 70
Generation of transgenic mice with mild and severe retinal neovascularisation
Lai, C.-M. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.059089 · Cited by 67
Bone spicule pigment formation in retinitis pigmentosa: insights from a mouse model
Jaissle, G. B., May, C. A., van de Pavert, S. A., Wenzel, A., Claes, E., Gießl, A., Szurman, P., Wolfrum, U., Wijnholds, J., Fisher, M. D., et al. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1253-9 · Cited by 65
Abnormal Glucose Metabolism and Parafoveal Telangiectasia
Millay, R. H., Klein, M. L., Handelman, I. L., & Watzke, R. C. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90012-7 · Cited by 65
FULL-THICKNESS MACULAR HOLE FORMATION IN IDIOPATHIC PARAFOVEAL TELANGIECTASIS
Koizumi, H., Slakter, J. S., & Spaide, R. F. (2007) · Retina · doi:10.1097/01.iae.0000246678.93495.2f · Cited by 60
SURGICAL REMOVAL OF SUBFOVEAL NEOVASCULARIZATION IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS
Berger, A. S., McCuen, B. W., Brown, G. C., et al. (1997) · Retina · doi:10.1097/00006982-199703000-00002 · Cited by 58
HISTOPATHOLOGIC STUDY OF PRESUMED PARAFOVEAL TELANGIECTASIS
Eliassi-Rad, B., & Green, W. R. (1999) · Retina · doi:10.1097/00006982-199907000-00011 · Cited by 57
Early Vascular and Neuronal Changes in a VEGF Transgenic Mouse Model of Retinal Neovascularization
van Eeden, P. E., Tee, L. B. G., Lukehurst, S., Lai, C., Rakoczy, E. P., Beazley, L. D., & Dunlop, S. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0251 · Cited by 56
Patients with Sjögren-Larsson Syndrome Lack Macular Pigment
van der Veen, R. L. P., Fuijkschot, J., Willemsen, M. A. A. P., Cruysberg, J. R. M., Berendschot, T. T. J. M., & Theelen, T. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.019 · Cited by 55
Analysis of visual pigment by fundus autofluorescence
Theelen, T., Berendschot, T. T. J. M., Boon, C. J. F., Hoyng, C. B., & Klevering, B. J. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.022 · Cited by 54
Schmitz-Valckenberg, S. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.3.330 · Cited by 54
Roller, A. B., Folk, J. C., Patel, N. M., Boldt, H. C., Russell, S. R., Abràmoff, M. D., & Mahajan, V. B. (2011) · Retina · doi:10.1097/iae.0b013e31820d3feb · Cited by 53
Metamorphopsia in patients with macular telangiectasia type 2
Issa, P. C., Holz, F. G., & Scholl, H. P. N. (2009) · Documenta Ophthalmologica · doi:10.1007/s10633-009-9190-9 · Cited by 52
Self-citationClinical Variations in Assessment of Bull's-eye Maculopathy
Kurz-Levin, M. M. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.5.567 · Cited by 51
Drenser, K. A., Sarraf, D., Jain, A., & Small, K. W. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.08.006 · Cited by 49
Fuijkschot, J., Cruysberg, J. R. M., Willemsen, M. A. A. P., KEUNEN, J. E. E., & Theelen, T. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.063 · Cited by 46
LONG-TERM JUXTAFOVEAL RETINAL TELANGIECTASIA
Watzke, R. C., Klein, M. L., Folk, J. C., Farmer, S. G., Munsen, R., CHAMPFER, R. J., & Sletten, K. R. (2005) · Retina · doi:10.1097/00006982-200509000-00007 · Cited by 41
STRUCTURAL AND FUNCTIONAL CHANGES OVER TIME IN MacTel PATIENTS
Schmitz-Valckenberg, S., Ong, E. L., Rubin, G. S., Pető, T., Tufail, A., Egan, C. A., Bird, A. C., & Fitzke, F. W. (2009) · Retina · doi:10.1097/iae.0b013e3181a4d2f1 · Cited by 41
Self-citationSNYERS, B., Verougstraete, C., Postelmans, L. D., LEYS, A. M., & Hykin, P. G. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.076 · Cited by 40
Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants
MacDonald, I. M., Sauvé, Y., & Sieving, P. A. (2007) · Canadian Journal of Ophthalmology · doi:10.3129/i07-039 · Cited by 39
Cherepanoff, S., Killingsworth, M. C., Zhu, M., Nolan, T., Hunyor, A. P., Young, S. H., Hageman, G. S., & Gillies, M. C. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301009 · Cited by 36
Self-citationThe Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations
Sallo, F. B., Leung, I., Mathenge, W. C., Kyari, F., Kuper, H., Gilbert, C. E., Bird, A. C., Pető, T., & on behalf of the MacTel Study Group (2012) · Ophthalmic Epidemiology · doi:10.3109/09286586.2011.638744 · Cited by 36
Self-citationWu, L., Evans, T., Arévalo, J. F., Berrocal, M. H., Rodriguez, F. J., HSU, M., & Sánchez, J. G. (2008) · Retina · doi:10.1097/iae.0b013e31814cf03e · Cited by 28
Analysis of candidate genes for macular telangiectasia type 2.
Parmalee, N. L., Schubert, C., Merriam, J. E., Allikmets, K., Bird, A. C., Gillies, M. C., Pető, T., Figueroa, M. J., Friedlander, M., Fruttiger, M., et al. (2010) · PubMed Central · Cited by 28
Self-citationGóralczyk, R., Buser, S., Bausch, J., Bee, W. H., Zühlke, U., & Barker, F. M. (1997) · PubMed · Cited by 26
Fibrovascular Tissue in Bilateral Juxtafoveal Telangiectasis
Park, D. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140294006 · Cited by 24
Rishi, P., Shroff, D., & Rishi, E. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0732-0 · Cited by 23
The Longitudinal Impact of Macular Telangiectasia (MacTel) Type 2 on Vision-Related Quality of Life
Lamoureux, E. L., Maxwell, R. M., Marella, M., Dirani, M., Fenwick, E., & Guymer, R. H. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6568 · Cited by 22
Basement membrane changes in capillaries of the ageing human retina
Powner, M. B., Scott, A. N., Zhu, M., Munro, P., Foss, A. J. E., Hageman, G. S., Gillies, M. C., & Fruttiger, M. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2011.204222 · Cited by 20
Self-citationShen, W., Zhang, J., Chung, S. H., Hu, Y., Ma, Z., & Gillies, M. C. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6033 · Cited by 20
Self-citationBILATERAL SUBRETINAL NEOVASCULAR MEMBRANE IN IDIOPATHIC JUXTAFOVEOLAR TELANGIECTASIS
Lee, B. L. (1996) · Retina · doi:10.1097/00006982-199616040-00014 · Cited by 18
Cited by
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., Shi, Y., & Wang, R. K. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.07.002 · Cited by 1,006
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Bernstein, P. S., Li, B., Vachali, P. P., Gorusupudi, A., Shyam, R., Henriksen, B. S., & Nolan, J. M. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.10.003 · Cited by 545
Retinal vasculature development in health and disease
Selvam, S., Kumar, T., & Fruttiger, M. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.001 · Cited by 353
Laíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
Metadata
- Authors
- Charbel Issa, P., Gillies, M. C., Chew, E. Y., Bird, A. C., Heeren, T. F. C., Peto, T., Holz, F. G., & Scholl, H. P. N.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 34
- Pages
- 49-77
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W1997402685
- Cited by
- 393
- References
- 91
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.